These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 12840909

  • 1. Multiple defects of cell cycle checkpoints in U937-ASPI3K, an U937 cell mutant stably expressing anti-sense ATM gene cDNA.
    Zhou J, Liu W, Sun L, Sun H, Tang Y.
    J Tongji Med Univ; 2000; 20(4):273-6. PubMed ID: 12840909
    [Abstract] [Full Text] [Related]

  • 2. Failure to inactivate CDK activity is responsible for the enhanced apoptotic response in U937 cells mediated by silencing ATM gene.
    Deng J, Zhou J, Meng F, Li D, Sun H.
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(3):193-6. PubMed ID: 12658801
    [Abstract] [Full Text] [Related]

  • 3. [The relationship between ATM gene silence inducing apoptosis susceptibility and abnormal CDK activity].
    Zhou JF, Tang Y, Liu WL, Sun HY, Hu JB, Gong JP.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Feb; 24(2):90-3. PubMed ID: 12697104
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An anti-sense construct of full-length ATM cDNA imposes a radiosensitive phenotype on normal cells.
    Zhang N, Chen P, Gatei M, Scott S, Khanna KK, Lavin MF.
    Oncogene; 1998 Aug 20; 17(7):811-8. PubMed ID: 9779997
    [Abstract] [Full Text] [Related]

  • 6. Defective control of apoptosis, radiosensitivity, and spindle checkpoint in ataxia telangiectasia.
    Takagi M, Delia D, Chessa L, Iwata S, Shigeta T, Kanke Y, Goi K, Asada M, Eguchi M, Kodama C, Mizutani S.
    Cancer Res; 1998 Nov 01; 58(21):4923-9. PubMed ID: 9810001
    [Abstract] [Full Text] [Related]

  • 7. [Establishment of the Cell Line U937-ASPI3K with Stable Expression of Antisense ATM/PI3K].
    Zhou JF, Liu WL, Tang Y, Dai QL, Sun L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Mar 01; 9(1):22-25. PubMed ID: 12578639
    [Abstract] [Full Text] [Related]

  • 8. ATM: the product of the gene mutated in ataxia-telangiectasia.
    Lavin MF.
    Int J Biochem Cell Biol; 1999 Jul 01; 31(7):735-40. PubMed ID: 10467728
    [Abstract] [Full Text] [Related]

  • 9. Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms.
    Siu WY, Lau A, Arooz T, Chow JP, Ho HT, Poon RY.
    Mol Cancer Ther; 2004 May 01; 3(5):621-32. PubMed ID: 15141020
    [Abstract] [Full Text] [Related]

  • 10. Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotype.
    Stewart GS, Last JI, Stankovic T, Haites N, Kidd AM, Byrd PJ, Taylor AM.
    J Biol Chem; 2001 Aug 10; 276(32):30133-41. PubMed ID: 11382771
    [Abstract] [Full Text] [Related]

  • 11. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G, Habbersett RC, Jia Y, Peterson SR, Lehnert BE, Bradbury EM, D'Anna JA.
    Oncogene; 1998 Feb 12; 16(6):721-36. PubMed ID: 9488036
    [Abstract] [Full Text] [Related]

  • 12. Human fibroblasts transfected with an ATM antisense vector respond abnormally to ionizing radiation.
    Uhrhammer N, Fritz E, Boyden L, Meyn MS.
    Int J Mol Med; 1999 Jul 12; 4(1):43-7. PubMed ID: 10373636
    [Abstract] [Full Text] [Related]

  • 13. Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM.
    Enoch T, Norbury C.
    Trends Biochem Sci; 1995 Oct 12; 20(10):426-30. PubMed ID: 8533157
    [Abstract] [Full Text] [Related]

  • 14. Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation.
    Xu B, Kim ST, Lim DS, Kastan MB.
    Mol Cell Biol; 2002 Feb 12; 22(4):1049-59. PubMed ID: 11809797
    [Abstract] [Full Text] [Related]

  • 15. Fragments of ATM which have dominant-negative or complementing activity.
    Morgan SE, Lovly C, Pandita TK, Shiloh Y, Kastan MB.
    Mol Cell Biol; 1997 Apr 12; 17(4):2020-9. PubMed ID: 9121450
    [Abstract] [Full Text] [Related]

  • 16. Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype.
    Gueven N, Becherel OJ, Birrell G, Chen P, DelSal G, Carney JP, Grattan-Smith P, Lavin MF.
    Cancer Res; 2006 Mar 15; 66(6):2907-12. PubMed ID: 16540636
    [Abstract] [Full Text] [Related]

  • 17. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G, Besnard E, Fisher D, Piette J, Dulić V.
    Oncogene; 2011 Oct 13; 30(41):4261-74. PubMed ID: 21532626
    [Abstract] [Full Text] [Related]

  • 18. Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin.
    Zimmermann M, Arachchige-Don AS, Donaldson MS, Dallapiazza RF, Cowan CE, Horne MC.
    J Biol Chem; 2012 Jun 29; 287(27):22838-53. PubMed ID: 22589537
    [Abstract] [Full Text] [Related]

  • 19. Dissecting cellular responses to irradiation via targeted disruptions of the ATM-CHK1-PP2A circuit.
    Palii SS, Cui Y, Innes CL, Paules RS.
    Cell Cycle; 2013 Apr 01; 12(7):1105-18. PubMed ID: 23462183
    [Abstract] [Full Text] [Related]

  • 20. Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype.
    Zhang N, Chen P, Khanna KK, Scott S, Gatei M, Kozlov S, Watters D, Spring K, Yen T, Lavin MF.
    Proc Natl Acad Sci U S A; 1997 Jul 22; 94(15):8021-6. PubMed ID: 9223307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.